IMUGENE FPO [IMU] (IMU.AX) Financials
IMU.AX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 230.4 million | 35.6 million |
2023-06-30 | 197.1 million | 7.4 million |
2023-03-31 | 197.1 million | 6.1 million |
2022-12-31 | 212.5 million | 5.1 million |
IMU.AX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -59.9 million | ? |
2023-06-30 | -9.2 million | 5.6 million |
2023-03-31 | -5.2 million | 2.8 million |
2022-12-31 | -20.6 million | ? |
IMU.AX Net Income
No data available :(
IMU.AX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 139.4 million | - | - |
2023-06-30 | 153.2 million | 362420 | 553472 |
2023-03-31 | 153.2 million | - | - |
2022-12-31 | 161.9 million | 427700 | - |
IMU.AX Shares Outstanding
IMU.AX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 11.5 million | 44.7 million | - | - |
2023-06-30 | - | 18.2 million | 11.2 million | - |
2023-03-31 | - | 9.1 million | 5.6 million | - |
2022-12-31 | - | 12.7 million | 9.3 million | - |
IMU.AX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-06-30 | 7.0 million | - |
2023-03-31 | 3.5 million | - |
2022-12-31 | 4.8 million | - |
IMU.AX
Price: A$0.08
52 week price:
Earnings Per Share: -0.01 AUD
P/E Ratio: -10.20
Exchange: ASX
Sector: Healthcare
Industry: Biotechnology
Volume: 7.4 million
Market Capitalization: 702.4 million